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mCongenital cystic adenomatoid malformation (CCAM) of the
ung is a congenital lesion that is sometimes complicated by bronchi-
loalveolar adenocarcinoma (BAC). In some cases foci of atypical
oblet cell hyperplasia (AGCH) can be found within the cysts. It has
een proposed that CCAM and AGCH predispose to the develop-
ent of BAC. The present study used comparative genomic hybrid-
zation (CGH) to screen 22 cases of CCAM (epithelium, surrounding
ormal lung tissue, and both preneoplastic and neoplastic lesions)
or chromosomal imbalances. Of these 22 cases, 10 were CCAM type
, 10 were type 2, and 2 were type 3. Of the 10 cases of CCAM type
, 2 were associated with AGCH, 1 was associated with atypical
denomatous hyperplasia (AAH) and associated tubular adenocarci-
oma (AC), and 2 were associated with BAC (1 mucinous and 1
redominantly nonmucinous). The present study also involved im-
unohistochemistry for interleukin (IL)-13, IL-4 receptor- (IL-4r),
ytokines involved in the differentiation of goblet cells, and mucin 2
rotein (Muc2). Chromosomal aberrations were not detected in the
pithelium or the surrounding normal lung tissue, whereas varying d
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565berrations were found in the neoplastic lesions. The most frequent
enomic imbalances observed in both AGCH and the carcinomas
ere gains in chromosomes 2 and 4. Interestingly, a predominance of
ains was also reported in AC of nonsmokers. Chromosomal aberra-
ions in AGCHs arising in CCAMs support their preneoplastic status.
uclear expression of IL-13, IL-4r, and Muc2 was detected in
GCH, whereas a cytoplasmic and nuclear reaction was seen in
ormal epithelium. This likely reflects an association with goblet cell
ifferentiation, but it also drives proliferation in AGCH.
UM PATHOL 35:565-570. © 2004 Elsevier Inc. All rights reserved.
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Abbreviations: AAH, atypical adenomatous hyperplasia; AC, ade-
ocarcinoma; AGCH, atypical goblet cell hyperplasia; BAC, bronchi-
loalveolar adenocarcinoma; CCAM, congenital cystic adenomatoid
alformation; CGH, comparative genomic hybridization; DOP-PCR,
egenerate oligonucleotide primer polymerase chain reaction.Congenital cystic adenomatoid malformations
CCAMs) are rare cystic lesions arising in the lung that
ere first grouped into 3 types based on their gross
ppearance: cystic, intermediate, and solid.1 Stocker
ater recommended that they be renamed types 1, 2,
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© 2004 Elsevier Inc. All rights reserved.nd 3,2 and later added types 0 and 4,3 envisioning that
he enlarged spectrum represented malformations of 5
uccessive groups of airways.
The pathogenesis of CCAMs is uncertain, but it
as been suggested that they represent maturation
efects at various points during organogenesis and
ifferentiation. They are diagnosed mainly in still-
orn fetuses or newborn infants, but sometimes are
ot detected until adulthood.4 Prenatal ultrasound
canning has also allowed their detection in utero.5
are cases of CCAM show malignant transformation,
sually bronchioloalveolar adenocarcinoma (BAC)
ithin a type 1 lesion.6
In addition to BAC, type 1 CCAMs demonstrate
ocal atypical goblet cell hyperplasia (AGCH) in ap-
roximately 33% of cases,7 although the incidence of
arcinomatous transformation is less than 1%. How-
ver, the only evidence that these lesions represent
rue malignancies is the rare incidence of metastatic
pread.8 Furthermore, the relationship between
GCH and BAC in terms of carcinogenesis is
ncertain.
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HUMAN PATHOLOGY Volume 35, No. 5 (May 2004)Consequently, the primary aim of the present
tudy was to investigate chromosomal aberrations in
ifferent types of CCAM, comparing changes in areas
f AGCH and BAC with the surrounding cysts and
ung parenchyma. In addition, because it is known
hat interleukin (IL)-13 is up-regulated in inflamed
issue and induces differentiation into goblet cells in
nimal models,9 with up-regulation of mucin 2 gene
Muc2) via a pathway that involves the IL-4 receptor
(IL-4R),10 this study also analyzed the expression
f IL-13, IL-4R, and Muc2 within areas of goblet cell
roliferation.
ATERIAL AND METHODS
tudy Samples
Participants in the European Project on Rare Pulmonary
iseases (funded by the Health & Consumer Protection Di-
ectorate General of the European Commission; project
001/RD/10010) collected 43 cases of CCAM as formalin-
xed, paraffin-embedded tissue blocks. Fourteen of these
pecimens were CCAM type 1, 25 were CCAM type 2, and 4
ere CCAM type 3. Two pathologists independently reviewed
he typing of CCAM. No cases of types 0 and 4 were identified.
ive cases of CCAM type 1 were associated with an AGCH, 1
ase of CCAM type 1 was combined with a multifocal atypical
denomatous hyperplasia (AAH), and 5 cases of CCAM type
were associated with AC. Patient age ranged from 27 gesta-
ional weeks to 41 years.
Sixteen cases demonstrating either significant inflamma-
ion or massive hemorrhage were rejected, including cases
ith degraded DNA. In 2 cases with ACs and 3 cases with
GCH present in cysts, there was insufficient material for
nalysis by comparative genomic hybridization (CGH).11 This
eft 22 cases for analysis, including 3 cases associated with foci
f AC, 1 case containing foci of AAH, and 2 cases with cysts
ontaining foci of AGCH (Table 1).
The tumor samples were examined and classified by an
xperienced pathologist. Sections for laser microdissection
Palm, Bernried, Germany) were stained with diluted Harris
ematoxylin solution (Merck, Darmstadt, Germany).
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
IGURE 1. CCAM type 1 with AGCH inside the cyst (patient
IGURE 2. AGCH within normal lung, adjacent to CCAM cyst
IGURE 3. AAH in normal lung adjacent to a CCAM cyst (pati
C (small arrow), which is attached to the CCAM cyst wall. (B)
osin; original magnification: A,  25, B,  100.)
IGURE 4. Mucinous BAC arising outside a CCAM cyst (patie
IGURE 5. Mixed mucinous and nonmucinous BAC adjace
TABLE 1. Clinical Data for the 5 Patients W
Age Sex
atient 1 3 years M Cystic lu
atient 2 Newborn F Cystic lu
atient 3 13 years M Cystic lu
atient 4 29 years M Tumor,
atient 5 3 years F Cystic lu
Abbreviations: fd, free of disease; pd, progressive disease.agnification  100.)
566In each case, epithelium lining the cysts and surrounding
ormal lung tissue, as well as areas of AGCH and BAC when
resent, were analyzed separately by CGH. AGCH was diag-
osed if mucous cell proliferations were found embedded in
he epithelium of the cysts or as small foci in adjacent alveoli.
AC was diagnosed when atypical cells formed single rows of
ells on alveolar walls completely replacing the normal epi-
helium.
omparative Genomic Hybridization
Genomic DNA from the tumors was extracted using stan-
ard proteinase K digestion. DNA was amplified by degener-
te oligonucleotide primer polymerase chain reaction (DOP-
CR) as described previously.12 In each round of DOP-PCR,
normal control was coamplified and also analyzed using
GH. All hybridizations were performed in a sex-mismatch
anner as an internal control. The Quips 3.1 software (Vysis,
owners Grove, IL) was used for CGH analysis. The well-
nown critical regions for CGH—1p36, 17p, 19p, 22, and the
elomeric and centromeric regions—were not analyzed. Only
ases where the sex mismatch was clearly identified by CGH
ere included. For each tumor sample, an average of 10
etaphase spreads was examined. Thresholds were set to 0.8
nd 1.2.
mmunohistochemistry
Anti–IL-13, anti–IL-4R, and anti-Muc2 (Santa Cruz Bio-
echnology, Santa Cruz, CA) were used as the primary anti-
odies as recommended. The incubation, washing steps, and
etection procedures were performed in routine fashion.
icrowave pretreatment was applied, with diaminobenzidine
ChemMed; Dako, Glostrup, Denmark) used as a chromo-
en, yielding a brown reaction product. Nuclei were counter-
tained slightly with hematoxylin.
ESULTS
omparative Genomic Hybridization
Twenty-two cases of CCAM (10 type 1, 10 type 2,
nd 2 type 3) were analyzed by CGH. Two cases of
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™3
ematoxylin and eosin; original magnification  100.)
tient 2). (Hematoxylin and eosin; original magnification  50.)
). (A) Overview showing 4 of the AAH foci and also the tubular
of the AAH foci enlarged (large arrow in A). (Hematoxylin and
. (Hematyoxylin and eosin; original magnification  200.)
a CCAM cyst (patient 5). (Hematoxylin and eosin; original
Preneoplastic Lesions or Adenocarcinoma
cal presentation Follow-up
esion Followed-up for 3 years; fd
esion fd
esion, suspicious tumor Follow-up for 11 years; fd
c lung lesion Follow-up for 2 years; alive, pd
esion, nodular lesion Follow-up for 16 years; fd™™™
1). (H
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HUMAN PATHOLOGY Volume 35, No. 5 (May 2004)CAM type 1 were associated with AGCH (Figs 1 and
). These lesions were found within the cysts and also
xtending into the surrounding lung. One case was
ombined with a multifocal AAH (Fig 3), 1 case was
ombined with a tubular AC (Fig 4), and 2 cases were
ombined with a mucinous and nonmucinous BAC
Fig 5).
Chromosomal aberrations were not detected in
he epithelium or in the surrounding normal lung
issue. Both cases of AGCH demonstrated aberrations
etected by CGH (Fig 6). Four of the 5 AAH foci (all
rom patient 3) had to be pooled because of their small
ize. Predominantly gains, but sometimes losses, were
ound in AGCH, AAH, and AC (Fig 6).
mmunohistochemistry
IL-13 exhibited a positive nuclear reaction in the
typical goblet cells and a positive cytoplasmic and
uclear reaction in the adjacent epithelium as well as in
nfiltrating lymphocytes and plasma cells (Fig 7A and
). In addition, macrophages and pneumocytes dem-
nstrated a positive nuclear and cytoplasmic reaction.
IL-4R and Muc2 were exclusively positive in the
uclei of atypical goblet cells (Fig 8A), whereas in
ontrols a positive cytoplasmic and nuclear reaction for
L-4R and Muc2 was seen in pneumocytes and some
eukocytes (Fig 8B). Bronchiolar (CCAM) epithelium
as negative for Muc2, but demonstrated cytoplasmic
IGURE 6. Summary of chromosomal aberrations in AGCH, A
, AGCH; 2, AGCH; 3, focus 1 of AAH; 4, pooled foci 2 to 5 ofnd nuclear positivity using Il4R antibodies. g
568ISCUSSION
No chromosomal aberrations were detected in ei-
her epithelium lining cysts or surrounding normal
issues. One reason for this might be that CCAM results
rom regional deregulation of involved genes at a spe-
ific time point during organogenesis and differentia-
ion, not by chromosomal imbalances. This process
ikely produces the different types of CCAM; for exam-
le, type 1 arises from cessation of development at the
accular stage. Point mutations and other alterations
hat cannot be detected by CGH may also account for
his abnormal differentiation.
The AGCHs demonstrated loss in chromosome 1
nd gains in chromosomes 2 and 4. In addition, 1 case
f goblet cell proliferation showed gain in chromosome
and loss in chromosome 8.
However, the most frequent genomic imbalances
ere gains in chromosomes 2 and 4. These are apparently
he initial chromosomal imbalances occurring during car-
inogenesis. Therefore, despite the small number of
ases, our study indicates that AGCH is a likely precursor
o ACs arising from CCAMs, because the same aberrations
ere also detected in the sampled ACs.
It is also interesting that chromosomal gains were
ore common than losses. In a study on ACs from non-
mokers,13 gains also predominated among the chromo-
omal aberrations. Another study based on unselected AC
ases, supposedly predominantly smokers, found that
14
nd AC, with gains on the right side and losses on the left side.
; 5, nonmucinous BAC; 6, mucinous BAC; 7, tubular AC.AH aains and losses were almost equally present. Thus dif-
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ATYPICAL GOBLET CELL HYPERPLASIA (Stacher et al)erent molecular pathways appear to be involved in the
evelopment of AC in smokers, nonsmokers, and child-
ood carcinomas arising in CCAM.
Another interesting finding was the exclusively nu-
lear staining for IL-4R and Muc2 stimulated by IL-13.
n contrast to internal controls outside CCAM, where
L-4R and Muc2 could be demonstrated in the cyto-
lasm, cell membrane, and nucleus, the staining in
GCH was exclusively nuclear. Therefore, nuclear
ranslocation of the IL-4R and up-regulation of Muc2
IGURE 7. Immunohistochemistry for IL-13. (A) Exclusive nuc
djacent normal epithelium as well as inflammatory cells. (B) N
ic as well as nuclear staining for IL-13 antibodies. (Original m
IGURE 8. Nuclear staining for Muc2 protein in AGCH (A),
pithelium and stroma cells (B). (Original magnification: A,  400; B
569ot only may be responsible for goblet differentiation,
ut also may be involved in neoplastic transformation,
imilar to the role that has been described for epider-
al growth factor receptor.15
In conclusion, whereas the respiratory-type surface
pithelium in CCAMs does not demonstrate chromo-
omal aberrations detectable by CGH, these aberrations
re present in putative precursor lesions (AGCH and
AH). Common genetic aberrations of putative precur-
or lesions and fully developed ACs are gains on chro-
staining in AGCH, with staining of nuclei and cytoplasm in
al lung parenchyma outside CCAM, with an intense cytoplas-
ification: A,  400; B,  100.)
focal cytoplasmic and nuclear staining in normal bronchiallear
orm
agnand
,  200.)
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HUMAN PATHOLOGY Volume 35, No. 5 (May 2004)osomes 2 and 4. This again stresses the importance of
omplete resection of the cysts.
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